Decoding the Glycomic Code: Beyond Genetic Centrality in Chemical Glycobiology Integrated with Bio-Inorganic Chemistry

This conceptual framework challenges the DNA-centric paradigm in molecular biology by positioning glycans as dynamic post-translational regulators of protein function, analogous to a hardware–software duality in computational systems. Chemical glycobiology is integrated with bio-inorganic chemistry to formalize the role of trace-metal cofactors in glycosylation enzymes. Every quantitative claim in this manuscript is generated by executable, disclosed code: torsional-potential equilibria are solved by bracketed root-finding (Brent's method) on a dimensionally consistent Fourier potential, correcting a degree/radian unit-mixing error in an earlier draft's combined harmonic-plus-Fourier form that had produced an internally inconsistent equilibrium classification; branching combinatorics are computed by exact molecular-formula arithmetic and enumerated by graph construction; a Markov-chain synthesis model is solved both in closed form (eigendecomposition) and by Monte Carlo simulation with bootstrap confidence intervals; global sensitivity analysis uses a from-scratch NumPy implementation of the Saltelli sampling scheme with Jansen (1999) first- and total-order estimators (10,000 base samples), because the SALib package was not available in the execution environment used to prepare this manuscript; the Hilbert–Schmidt independence criterion is computed with a properly centered kernel estimator and validated by a 300-replicate permutation test; Bayesian posteriors are obtained both analytically (conjugate priors) and via an independently coded Metropolis–Hastings sampler with a genuine multi-chain Gelman–Rubin diagnostic; and a multilayer-perceptron classifier is trained on an explicitly synthetic, disclosed feature set rather than on an unstated or fictitious biological dataset. Where the original analysis plan called for empirical correlations that could not be sourced from verifiable, cited data (e.g., glycan-integrity/cognition or IgG-fucosylation/severity associations), these are presented transparently as illustrative synthetic examples of the analytical pipeline rather than as empirical findings. All references were checked against PubMed, CrossRef, and publisher records; one previously mis-cited reference (author list and DOI) is corrected, and two references are added with verified DOIs: a contemporaneous AI-genomics reference (Mount Sinai's V2P tool, Nature Communications, 2025) and a population-genetics-based prevalence estimate for congenital disorders of glycosylation, replacing an uncited figure carried over from an earlier draft. The manuscript's central falsifiability criteria, risk assessment, and validation roadmap are retained and expanded, consistent with Popperian standards of empirical accountability.